MTOR and neoplasm: One study analyzed publicly available tumor genome sequence data from more than 400 samples, and identified 33 mutations in MTOR related to hyperactivation, which can strongly activate the downstream effectors (4EBP1 and S6K1) to promote the tumorigenesis [130].